½ÃÀ庸°í¼­
»óǰÄÚµå
1450858

½Å¼Ó °Ë»ç ŰƮ - ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø, ¼¼°è ¹× Áö¿ªº° Á¡À¯À², µ¿Çâ ¹× ¼ºÀå ±âȸ ºÐ¼® º¸°í¼­ : Á¦Ç° À¯Çüº°, ±â¼úº°, ¿ëµµº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº°

Rapid Test Kits Market Size and Forecasts, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Product, Technology, Application, End User, and Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: The Insight Partners | ÆäÀÌÁö Á¤º¸: ¿µ¹® 279 Pages | ¹è¼Û¾È³» : Áï½Ã¹è¼Û

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

2022³â ½ÃÀå ±Ô¸ð´Â 177¾ï 2,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú½À´Ï´Ù. 2030³â¿¡´Â 266¾ï 3,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2022-2030³â°£ ¿¬Æò±Õ 5.2%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù.

½Å¼Ó°Ë»ç´Â »ç¿ëÀÌ °£ÆíÇÏ°í °á°ú°¡ »¡¸® ³ª¿À±â ¶§¹®¿¡ Á¾Á¾ ½Å¼ÓÁø´Ü°Ë»ç(RDT)¶ó°í ºÒ¸³´Ï´Ù. ½Å¼Ó °Ë»ç´Â °Ë»ç ±â°ü¿¡ Á¦ÃâÇØ¾ß ÇÏ´Â ´ëºÎºÐÀÇ ÀÏ»óÀûÀÎ °Ë»ç¿Í ´Þ¸® Áø·á ½ÃÁ¡¿¡ ½ÃÇàµË´Ï´Ù. ÀÌ Å°Æ®´Â »ý¹°ÀÇ ±âÀú ÁúȯÀ» ½Äº°ÇÏ°í ¸ð´ÏÅ͸µÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ½Å¼Ó °Ë»ç ŰƮÀÇ ÁÖ¿ä ¸ñÀûÀº Ãʱ⠼±º° °Ë»çÀÌÁö¸¸ ÀÚ¿øÀÌ ºÎÁ·ÇÑ »óȲ¿¡¼­ ¸Å¿ì À¯¿ëÇÕ´Ï´Ù. ½Å¼Ó °Ë»ç ŰƮÀÇ ÁÖ¿ä ¿ëµµ´Â Äڷγª19, HIV, ¸»¶ó¸®¾Æ, ¿¬¼â»ó±¸±Õ °¨¿°, µ¶°¨ µî °¨¿°¼º ÁúȯÀÇ Áø´Ü¿¡ ÁÖ·Î »ç¿ëµË´Ï´Ù.

¸ÖƼÇ÷º½º ½Å¼Ó Ç׿ø °Ë»ç´Â ´Ù»ö ³ª³ë ÀÔÀÚ¿Í ±³Â÷ ¹ÝÀÀ¼º Ç×ü¸¦ ±â¹ÝÀ¸·Î Çϸç, ÀÌ·¯ÇÑ °Ë»ç ŰƮ´Â Àú·ÅÇÑ ºñ¿ëÀ¸·Î °³¹ßÇÒ ¼ö ÀÖ½À´Ï´Ù. ´ÙÁß ½Å¼Ó Áø´Ü °Ë»ç´Â ´Ù¾çÇÑ È£Èí±â º´¿øÃ¼°¡ µ¿½Ã¿¡ ¼÷ÁÖ Ã¼³»¿¡¼­ ¼øÈ¯ÇÏ´Â °æ¿ì ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü°¡ ȯÀÚ¸¦º¸´Ù È¿°úÀûÀ¸·Î °¨µ¶ ÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù. ÀÌ·¯ÇÑ °Ë»ç´Â ÀÓ»ó Áõ»óÀÇ Áߺ¹À¸·Î ÀÎÇÑ ¿ÀÁø °¡´É¼ºÀ» ¹æÁöÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. Áø´ÜÀÇ ºÒÈ®½Ç¼ºÀ» Á¦°ÅÇÔÀ¸·Î½á ÀÇ·áÁøÀÌ Ç×±ÕÁ¦ Ä¡·áÀÇ ½ÃÀÛ°ú Áß´Ü¿¡ ´ëÇÑ ÀûÀýÇÑ ÆÇ´ÜÀ» ³»¸± ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù. ´ÜÀÏ °Ëü Ç׿ø °Ë»ç ŰƮ¿Í ´Þ¸®, ´ÙÁß Ç׿ø ½Å¼Ó °Ë»ç ŰƮ´Â °á°úÀÇ ÁúÀ» ¶³¾î¶ß¸®Áö ¾Ê°í ÇÑ °Ëü¿¡¼­ ¸¹Àº È£Èí±â ¹ÙÀÌ·¯½º¸¦ °ËÃâÇÒ ¼ö ÀÖÀ¸¸ç, UK-Rapid Test Consortium(UK-RTC)À» ´ëÇ¥ÇÏ¿© ¿µ±¹ Á¤ºÎ´Â AbC-19 ½Å¼Ó Ç×ü °Ë»ç Á¶´Þ °è¾àÀ» Abingdon Health»ç¿¡ ¹ßÁÖÇß½À´Ï´Ù. ÀÌ °è¾àÀº ¿µ±¹ Á¤ºÎ°¡ ÀÇ·ÚÇÑ ÀÌ ½Å¼Ó Ç×ü °Ë»ç¿¡ ´ëÇÑ µ¶¸³ÀûÀÎ Æò°¡¿¡ µû¸¥ °ÍÀÔ´Ï´Ù. µû¶ó¼­ ÇâÈÄ ¸î ³âµ¿¾È ¸ÖƼÇ÷º½º ½Å¼Ó Ç׿ø °Ë»ç¿Í °°Àº Çõ½ÅÀÌ »õ·Î¿î ½Å¼Ó °Ë»ç ŰƮ ½ÃÀåÀÇ Æ®·»µå·Î ºÎ»óÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

.

±â¼úº°, ½Å¼Ó °Ë»ç ŰƮ ½ÃÀå ±â¹Ý ÀλçÀÌÆ®

±â¼úº°·Î ½Å¼Ó °Ë»ç ŰƮ ½ÃÀåÀº Ãø¸é È帧 ºÐ¼®, °íü»ó, ÀÀÁý, ¸é¿ª ½ºÆÌ ºÐ¼®, ¼¼Æ÷ ¼ººÐ ±â¹Ý µîÀ¸·Î ºÐ·ùµË´Ï´Ù. Ãø¸é È帧 ºÐ¼® ºÐ¾ß´Â 2022³â ½Å¼Ó °Ë»ç ŰƮ ½ÃÀå¿¡¼­ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2022-2023³â CAGRÀº 5.7%·Î °¡Àå ³ôÀ» °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Ãø¸é È帧 ºÐ¼®(LFA)Àº º¹ÀâÇÑ È¥ÇÕ¹°¿¡¼­ ºÐ¼®¹°À» °ËÃâÇϰųª Á¤·®È­Çϱâ À§ÇØ °Ë»ç ±â±â¿¡ ³»ÀåµÈ Á¾ÀÌ ±â¹Ý Ç÷§ÆûÀÔ´Ï´Ù. °¡½ÃÀûÀÎ °á°ú´Â 5-30ºÐ À̳»¿¡ ¾òÀ» ¼ö ÀÖ½À´Ï´Ù. º´¿ø, Ŭ¸®´Ð ¹× ÀÓ»ó ½ÇÇè½Ç¿¡¼­ LFA ±â¹Ý ºÐ¼®Àº ƯÁ¤ Ç׿ø, Ç×ü ¹× À¯ÀüÀÚ/DNA ÁõÆø »ê¹°ÀÇ Á¤¼º ¹× Á¤·® °ËÃâÀ» À§ÇØ ÀÚÁÖ »ç¿ëµÇ¸ç, ÀüÇ÷, Ç÷û, Ç÷Àå, ¶¡, Ÿ¾×, ¼Òº¯ µî ´Ù¾çÇÑ »ý¹°ÇÐÀû »ùÇÃÀ» °Ë»çÇÏ´Â µ¥ »ç¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. Ãø¸é È帧 ºÐ¼®Àº ÇöÀå Áø·á(Point-of-Care) ȯ°æ¿¡¼­ À¯¿ëÇϰí ÀûÀÀ·ÂÀÌ ¶Ù¾î³­ Áø´Ü µµ±¸ÀÔ´Ï´Ù.

½Å¼Ó°Ë»çŰƮ ½ÃÀå À¯Çüº° ÀλçÀÌÆ®

À¯Çüº°·Î´Â ½Å¼Ó Ç׿ø °Ë»ç, ½Å¼Ó Ç×ü °Ë»ç, ±âŸ·Î ºÐ·ùµÇ¸ç, 2022³â¿¡´Â ½Å¼Ó Ç׿ø °Ë»ç ºÎ¹®ÀÌ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇßÀ¸¸ç, 2022-2023³â CAGRÀº 6.0%·Î °¡Àå ³ôÀ» °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. Ç׿øÀº ¼÷ÁÖÀÇ ¸ö¿¡ µé¾î°¡¸é ¸é¿ª ¹ÝÀÀÀ» ÀÏÀ¸Åµ´Ï´Ù. È­ÇÐ ¹°Áú, ¹ÙÀÌ·¯½º, ¹ÚÅ׸®¾Æ, µ¶¼Ò¿Í °°Àº ºñ¼÷ÁÖ ¹°ÁúÀº ü³»¿¡¼­ ¸é¿ªÇÐÀû ¹ÝÀÀÀ» ÀÏÀ¸Å³ ¼ö ÀÖ½À´Ï´Ù. ½Åü Á¶Á÷À̳ª ¼¼Æ÷ ³»¿¡ Á¸ÀçÇÏ´Â Ç׿øµµ ¸é¿ª ¹ÝÀÀÀ» ÀÏÀ¸Å³ ¼ö ÀÖ½À´Ï´Ù. ½Å¼Ó Ç׿ø °Ë»çÀÇ ¸ÞÄ¿´ÏÁòÀº äÃëÇÑ °Ëü¿¡¼­ ÀÌ·¯ÇÑ Ç׿øÀ» °ËÃâÇÏ´Â °ÍÀ» Æ÷ÇÔÇÕ´Ï´Ù. ºü¸¥ °á°ú¿Í »ç¿ë ÆíÀǼºÀº ½Å¼Ó Ç׿ø °Ë»ç ŰƮÀÇ ÁÖ¿ä ÀåÁ¡ÀÔ´Ï´Ù. ¿¹¸¦ µé¾î, iHealthÀÇ Äڷγª19 Ç׿ø ½Å¼Ó °Ë»ç´Â FDA ½ÂÀÎÀ» ¹ÞÀº ½ÃÆÇ¿ë ÀÚ°¡ °ü¸® °Ë»ç·Î 15ºÐ ¸¸¿¡ °á°ú¸¦ ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

Áúº´°ü¸®º»ºÎ(Centers for Disease Control and Prevention)¿Í ±â¾÷ÀÇ ¹é¼­´Â ½Å¼Ó Ç׿ø °Ë»ç ŰƮ ½ÃÀå¿¡ ´ëÇÑ º¸°í¼­¸¦ ÀÛ¼ºÇÒ ¶§ Âü°íÇÑ ÁÖ¿ä º¸Á¶ Á¤º¸ Áß ÀϺÎÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ÁÖ¿ä ÀλçÀÌÆ®
  • ½Å¼Ó °Ë»ç ŰƮ ½ÃÀå : Áö¿ªº°

Á¦3Àå Á¶»ç ¹æ¹ý

  • Á¶»ç ¹üÀ§
  • 2Â÷ Á¶»ç
  • 1Â÷ Á¶»ç

Á¦4Àå ½Å¼Ó °Ë»ç ŰƮ ½ÃÀå ±¸µµ

  • ¼¼°èÀÇ PEST ºÐ¼®

Á¦5Àå ½Å¼Ó °Ë»ç ŰƮ ½ÃÀå - ÁÖ¿ä »ê¾÷ ¿ªÇÐ

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ½ÃÀå ±âȸ
  • ÇâÈÄ µ¿Çâ
  • ¿µÇ⠺м®

Á¦6Àå ½Å¼Ó °Ë»ç ŰƮ ½ÃÀå : ¼¼°è ½ÃÀå ºÐ¼®

  • ½Å¼Ó °Ë»ç ŰƮ ½ÃÀå ¸ÅÃâ, 2022³â-2030³â

Á¦7Àå ½Å¼Ó °Ë»ç ŰƮ ½ÃÀå ºÐ¼® ½Å¼Ó °Ë»ç ŰƮ ½ÃÀå ºÐ¼® - À¯Çüº°

  • ½Å¼Ó Ç׿ø °Ë»ç
  • ½Å¼Ó Ç×ü °Ë»ç
  • ±âŸ

Á¦8Àå ½Å¼Ó °Ë»ç ŰƮ ½ÃÀå ºÐ¼® - Á¦Ç°º°

  • ½ÃÆÇ¿ë ½Å¼Ó °Ë»ç ŰƮ
  • Àü¹®¿ë ½Å¼Ó °Ë»ç ŰƮ

Á¦9Àå ½Å¼Ó °Ë»ç ŰƮ ½ÃÀå ºÐ¼® : ±â¼úº°

  • Ãø¸é È帧 ºÐ¼®
  • °í»ó¹ý
  • ÀÀÁý
  • ¸é¿ª ½ºÆÌ ºÐ¼®
  • ¼¼Æ÷ ¼ººÐ ±â¹Ý

Á¦10Àå ½Å¼Ó °Ë»ç ŰƮ ½ÃÀå ºÐ¼® : ¿ëµµº°

  • Ç÷´ç °Ë»ç
  • °¨¿°Áõ °Ë»ç
  • ¼øÈ¯ ´ë»ç °Ë»ç
  • ÀӽŠ¹× ºÒÀÓ °Ë»ç
  • ±âŸ

Á¦11Àå ½Å¼Ó °Ë»ç ŰƮ ½ÃÀå ºÐ¼® : ÃÖÁ¾»ç¿ëÀÚº°

  • º´¿ø ¹× Áø·á¼Ò
  • Áø´Ü¼¾ÅÍ
  • ÀçÅÃÄ¡·á
  • ±âŸ

Á¦12Àå ½Å¼Ó °Ë»ç ŰƮ ½ÃÀå : Áö¿ªº° ºÐ¼®

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • È£ÁÖ
    • Çѱ¹
    • APAC ±âŸ ±¹°¡
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
  • Áß³²¹Ì
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • ±âŸ Áß³²¹Ì

Á¦13Àå ¾÷°è »óȲ

  • ½Å¼Ó °Ë»ç ŰƮ ½ÃÀå ¼ºÀå Àü·«
  • ¹«±âÀû ¼ºÀå Àü·«
  • À¯±âÀû ¼ºÀå Àü·«

Á¦14Àå ±â¾÷ °³¿ä

  • F. Hoffmann-La Roche Ltd
  • Becton Dickinson and Co
  • ARKRAY Inc
  • Sysmex Partec GmbH
  • Fujirebio Europe NV
  • bioMerieux SA
  • Cepheid
  • Meril Life Sciences Pvt Ltd
  • QIAGEN NV
  • OraSure Technologies Inc
  • Guangzhou Wondfo Biotech Co Ltd
  • Denka Co Ltd
  • Abbott Laboratories
  • Trinity Biotech Plc
  • SD Biosensor Inc
  • Bio-Rad Laboratories Inc
  • Hologic Inc
  • DiaSorin SpA
  • Premier Medical Corp Pvt Ltd
  • Beckman Coulter Inc

Á¦15Àå ºÎ·Ï

LSH 24.04.26

The market was valued at US$ 17.72 billion in 2022 and is expected to reach US$ 26.63 billion by 2030. It is estimated to register a CAGR of 5.2% from 2022 to 2030.

Rapid tests are simple to use and provide quick results; they are often referred to as rapid diagnostic tests (RDTs). Rapid tests are performed at the point of care, in contrast to the majority of routine tests, which have to be submitted to a lab; moreover, they generate results at the point of care. These kits aid in the identification and monitoring of underlying illnesses in living things. Although rapid test kits serve the primary purpose of initial screening, they prove highly beneficial in situations with scanty resource availability. The prime application of rapid test kits is to diagnose infectious disorders such as COVID-19, HIV, malaria, strep throat, and flu.

Operations of multiplex rapid antigen tests are based on multicolored nanoparticles and cross-reactive antibodies, and these test kits can be developed at low costs. Rapid multiplex diagnostic testing helps healthcare providers supervise their patients with greater effectiveness when various respiratory pathogens are circulating simultaneously in a host body. These tests can help avoid possible misdiagnosis due to overlapping clinical symptoms. By eliminating diagnostic uncertainty, they help healthcare providers make apt decisions about the commencement and discontinuation of antimicrobial therapies. Unlike single specimen antigen test kits, multiplex rapid antigen test kits can detect many respiratory viruses from a single specimen without compromising the quality of results. On behalf of the UK-Rapid Test Consortium (UK-RTC), the UK Government has awarded a contract to Abingdon Health to procure the AbC-19 rapid antibody tests. The contract follows an independent evaluation of this rapid antibody test, commissioned by the UK Government. Therefore, innovations such as multiplex rapid antigen tests are expected to emerge as new rapid test kits market trends in the coming years.

.

By Technology, Rapid Test Kits Market-Based Insights

By technology, the rapid test kits market is segmented into lateral flow assay, solid phase, agglutination, immunospot assay, and cellular component-based. The lateral flow assay segment held the largest rapid test kits market share in 2022 and is anticipated to register the highest CAGR of 5.7% during 2022- 2023. A lateral flow assay (LFA) is a paper-based platform embedded in test equipment to detect or quantify analytes in complex mixtures. Visible results are obtained within the window of 5-30 minutes. In hospitals, doctor's offices, and clinical laboratories, LFA-based assays are frequently utilized for the qualitative and quantitative detection of particular antigens, antibodies, and gene/DNA amplification products. LFAs can be used to examine a wide range of biological samples, such as whole blood, serum, plasma, perspiration, saliva, and urine. Lateral flow assays are a valuable and adaptable diagnostic tool for point-of-care settings.

By Type, Rapid Test Kits Market -Based Insights

In terms of type, the rapid test kits market is categorized into segmented into rapid antigen testing, rapid antibody testing, and others. The rapid antigen testing segment held the largest market share in 2022. It is anticipated that the highest CAGR of 6.0% will be registered during 2022- 2023. An antigen can cause an immunological reaction upon entering the host body. Any nonhost materials such as chemicals, viruses, bacteria, or toxins can trigger an immunological response in the body. Antigens found in body tissues and cells can also cause immune responses. The mechanism of a rapid antigen test involves detecting such antigens in collected samples. Speedy results and ease of use are the primary benefits of rapid antigen test kits. For instance, the iHealth COVID-19 Antigen Rapid Test is an FDA-authorized, over-the-counter, self-administered test that delivers results in 15 minutes.

Centers for Disease Control and Prevention and companies white papers are a few of the major secondary sources referred to while preparing the report on the rapid test kits market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 Rapid Test Kits Market, by Geography (US$ Million)

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Rapid Test Kits Market Landscape

  • 4.1 Overview
  • 4.2 Global PEST Analysis

5. Rapid Test Kits Market - Key Industry Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Rising Prevalence of Genetic and Infectious Diseases
    • 5.1.2 Strategic Initiatives by Manufacturers
  • 5.2 Market Restraints
    • 5.2.1 Uncertainties Related to Accuracy of Results
  • 5.3 Market Opportunities
    • 5.3.1 Increasing Preference for PCR Techniques
  • 5.4 Future Trends
    • 5.4.1 Innovations in Rapid Antigen Tests
  • 5.5 Impact Analysis

6. Rapid Test Kits Market - Global Market Analysis

  • 6.1 Rapid Test Kits Market Revenue (US$ Mn), 2022 - 2030

7. Rapid Test Kits Market Analysis - by Type

  • 7.1 Overview
  • 7.2 Rapid Antigen Testing
    • 7.2.1 Overview
    • 7.2.2 Rapid Antigen Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.3 Rapid Antibody Testing
    • 7.3.1 Overview
    • 7.3.2 Rapid Antibody Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Others
    • 7.4.1 Overview
    • 7.4.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

8. Rapid Test Kits Market Analysis - by Product

  • 8.1 Overview
  • 8.2 Over-the-Counter Rapid Testing Kit
    • 8.2.1 Overview
    • 8.2.2 Over-the-Counter Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.3 Professional Rapid Testing Kit
    • 8.3.1 Overview
    • 8.3.2 Professional Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

9. Rapid Test Kits Market Analysis - by Technology

  • 9.1 Overview
  • 9.2 Lateral Flow Assay
    • 9.2.1 Overview
    • 9.2.2 Lateral Flow Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.3 Solid Phase
    • 9.3.1 Overview
    • 9.3.2 Solid Phase: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Agglutination
    • 9.4.1 Overview
    • 9.4.2 Agglutination: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Immunospot Assay
    • 9.5.1 Overview
    • 9.5.2 Immunospot Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Cellular-Component Based
    • 9.6.1 Overview
    • 9.6.2 Cellular-Component Based: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

10. Rapid Test Kits Market Analysis - by Application

  • 10.1 Overview
  • 10.2 Blood Glucose Testing
    • 10.2.1 Overview
    • 10.2.2 Blood Glucose Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.3 Infectious Disease Testing
    • 10.3.1 Overview
    • 10.3.2 Infectious Disease Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.4 Cardiometabolic Testing
    • 10.4.1 Overview
    • 10.4.2 Cardiometabolic Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.5 Pregnancy and Fertility
    • 10.5.1 Overview
    • 10.5.2 Pregnancy and Fertility: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.6 Others
    • 10.6.1 Overview
    • 10.6.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

11. Rapid Test Kits Market Analysis - by End User

  • 11.1 Overview
  • 11.2 Hospital and Clinics
    • 11.2.1 Overview
    • 11.2.2 Hospital and Clinics: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 11.3 Diagnostic Centers
    • 11.3.1 Overview
    • 11.3.2 Diagnostic Centers: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 11.4 Home-Care
    • 11.4.1 Overview
    • 11.4.2 Home-Care: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 11.5 Others
    • 11.5.1 Overview
    • 11.5.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

12. Rapid Test Kits Market - Geographical Analysis

  • 12.1 North America: Rapid Test Kits Market
    • 12.1.1 Overview
    • 12.1.2 North America: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
      • 12.1.2.1 North America: Rapid Test Kits Market - Revenue and Forecast Analysis - by Type
      • 12.1.2.2 North America: Rapid Test Kits Market - Revenue and Forecast Analysis - by Product
      • 12.1.2.3 North America: Rapid Test Kits Market - Revenue and Forecast Analysis - by Technology
      • 12.1.2.4 North America: Rapid Test Kits Market - Revenue and Forecast Analysis - by Application
        • 12.1.2.4.1 North America: Rapid Test Kits Market - Revenue and Forecast Analysis - by Infectious Disease Testing
      • 12.1.2.5 North America: Rapid Test Kits Market - Revenue and Forecast Analysis - by End User
    • 12.1.3 North America: Rapid Test Kits Market - Revenue and Forecast Analysis - by Country
      • 12.1.3.1 United States: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.1.3.1.1 Overview
      • 12.1.3.2 United States: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.1.3.2.1 United States: Rapid Test Kits Market Breakdown, by Type
        • 12.1.3.2.2 United States: Rapid Test Kits Market Breakdown, by Product
        • 12.1.3.2.3 United States: Rapid Test Kits Market Breakdown, by Technology
        • 12.1.3.2.4 United States: Rapid Test Kits Market Breakdown, by Application
        • 12.1.3.2.4.1 United States: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
        • 12.1.3.2.5 United States: Rapid Test Kits Market Breakdown, by End User
      • 12.1.3.3 Canada: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.1.3.3.1 Overview
      • 12.1.3.4 Canada: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.1.3.4.1 Canada: Rapid Test Kits Market Breakdown, by Type
        • 12.1.3.4.2 Canada: Rapid Test Kits Market Breakdown, by Product
        • 12.1.3.4.3 Canada: Rapid Test Kits Market Breakdown, by Technology
        • 12.1.3.4.4 Canada: Rapid Test Kits Market Breakdown, by Application
        • 12.1.3.4.4.1 Canada: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
        • 12.1.3.4.5 Canada: Rapid Test Kits Market Breakdown, by End User
      • 12.1.3.5 Mexico: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.1.3.5.1 Overview
      • 12.1.3.6 Mexico: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.1.3.6.1 Mexico: Rapid Test Kits Market Breakdown, by Type
        • 12.1.3.6.2 Mexico: Rapid Test Kits Market Breakdown, by Product
        • 12.1.3.6.3 Mexico: Rapid Test Kits Market Breakdown, by Technology
        • 12.1.3.6.4 Mexico: Rapid Test Kits Market Breakdown, by Application
        • 12.1.3.6.4.1 Mexico: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
        • 12.1.3.6.5 Mexico: Rapid Test Kits Market Breakdown, by End User
  • 12.2 Europe
    • 12.2.1 Overview
    • 12.2.2 Europe: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
      • 12.2.2.1 Europe: Rapid Test Kits Market - Revenue and Forecast Analysis - by Type
      • 12.2.2.2 Europe: Rapid Test Kits Market - Revenue and Forecast Analysis - by Product
      • 12.2.2.3 Europe: Rapid Test Kits Market - Revenue and Forecast Analysis - by Technology
      • 12.2.2.4 Europe: Rapid Test Kits Market - Revenue and Forecast Analysis - by Application
        • 12.2.2.4.1 Europe: Rapid Test Kits Market - Revenue and Forecast Analysis - by Infectious Disease Testing
      • 12.2.2.5 Europe: Rapid Test Kits Market - Revenue and Forecast Analysis - by End User
    • 12.2.3 Europe: Rapid Test Kits Market - Revenue and Forecast Analysis - by Country
      • 12.2.3.1 Germany: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.2.3.1.1 Overview
      • 12.2.3.2 Germany: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.2.3.2.1 Germany: Rapid Test Kits Market Breakdown, by Type
        • 12.2.3.2.2 Germany: Rapid Test Kits Market Breakdown, by Product
        • 12.2.3.2.3 Germany: Rapid Test Kits Market Breakdown, by Technology
        • 12.2.3.2.4 Germany: Rapid Test Kits Market Breakdown, by Application
        • 12.2.3.2.4.1 Germany: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
        • 12.2.3.2.5 Germany: Rapid Test Kits Market Breakdown, by End User
      • 12.2.3.3 United Kingdom: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.2.3.3.1 Overview
      • 12.2.3.4 United Kingdom: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.2.3.4.1 United Kingdom: Rapid Test Kits Market Breakdown, by Type
        • 12.2.3.4.2 United Kingdom: Rapid Test Kits Market Breakdown, by Product
        • 12.2.3.4.3 United Kingdom: Rapid Test Kits Market Breakdown, by Technology
        • 12.2.3.4.4 United Kingdom: Rapid Test Kits Market Breakdown, by Application
        • 12.2.3.4.4.1 United Kingdom: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
        • 12.2.3.4.5 United Kingdom: Rapid Test Kits Market Breakdown, by End User
      • 12.2.3.5 France: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.2.3.5.1 Overview
      • 12.2.3.6 France: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.2.3.6.1 France: Rapid Test Kits Market Breakdown, by Type
        • 12.2.3.6.2 France: Rapid Test Kits Market Breakdown, by Product
        • 12.2.3.6.3 France: Rapid Test Kits Market Breakdown, by Technology
        • 12.2.3.6.4 France: Rapid Test Kits Market Breakdown, by Application
        • 12.2.3.6.4.1 France: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
        • 12.2.3.6.5 France: Rapid Test Kits Market Breakdown, by End User
      • 12.2.3.7 Italy: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.2.3.7.1 Overview
      • 12.2.3.8 Italy: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.2.3.8.1 Italy: Rapid Test Kits Market Breakdown, by Type
        • 12.2.3.8.2 Italy: Rapid Test Kits Market Breakdown, by Product
        • 12.2.3.8.3 Italy: Rapid Test Kits Market Breakdown, by Technology
        • 12.2.3.8.4 Italy: Rapid Test Kits Market Breakdown, by Application
        • 12.2.3.8.4.1 Italy: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
        • 12.2.3.8.5 Italy: Rapid Test Kits Market Breakdown, by End User
      • 12.2.3.9 Spain: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.2.3.9.1 Overview
      • 12.2.3.10 Spain: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.2.3.10.1 Spain: Rapid Test Kits Market Breakdown, by Type
        • 12.2.3.10.2 Spain: Rapid Test Kits Market Breakdown, by Product
        • 12.2.3.10.3 Spain: Rapid Test Kits Market Breakdown, by Technology
        • 12.2.3.10.4 Spain: Rapid Test Kits Market Breakdown, by Application
        • 12.2.3.10.4.1 Spain: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
        • 12.2.3.10.5 Spain: Rapid Test Kits Market Breakdown, by End User
      • 12.2.3.11 Rest of Europe: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.2.3.11.1 Overview
      • 12.2.3.12 Rest of Europe: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.2.3.12.1 Rest of Europe: Rapid Test Kits Market Breakdown, by Type
        • 12.2.3.12.2 Rest of Europe: Rapid Test Kits Market Breakdown, by Product
        • 12.2.3.12.3 Rest of Europe: Rapid Test Kits Market Breakdown, by Technology
        • 12.2.3.12.4 Rest of Europe: Rapid Test Kits Market Breakdown, by Application
        • 12.2.3.12.4.1 Rest of Europe: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
        • 12.2.3.12.5 Rest of Europe: Rapid Test Kits Market Breakdown, by End User
  • 12.3 Asia Pacific
    • 12.3.1 Overview
    • 12.3.2 Asia Pacific: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
      • 12.3.2.1 Asia Pacific: Rapid Test Kits Market - Revenue and Forecast Analysis - by Type
      • 12.3.2.2 Asia Pacific: Rapid Test Kits Market - Revenue and Forecast Analysis - by Product
      • 12.3.2.3 Asia Pacific: Rapid Test Kits Market - Revenue and Forecast Analysis - by Technology
      • 12.3.2.4 Asia Pacific: Rapid Test Kits Market - Revenue and Forecast Analysis - by Application
        • 12.3.2.4.1 Asia Pacific: Rapid Test Kits Market - Revenue and Forecast Analysis - by Infectious Disease Testing
      • 12.3.2.5 Asia Pacific: Rapid Test Kits Market - Revenue and Forecast Analysis - by End User
    • 12.3.3 Asia Pacific: Rapid Test Kits Market - Revenue and Forecast Analysis - by Country
      • 12.3.3.1 China: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.3.3.1.1 Overview
      • 12.3.3.2 China: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.3.3.2.1 China: Rapid Test Kits Market Breakdown, by Type
        • 12.3.3.2.2 China: Rapid Test Kits Market Breakdown, by Product
        • 12.3.3.2.3 China: Rapid Test Kits Market Breakdown, by Technology
        • 12.3.3.2.4 China: Rapid Test Kits Market Breakdown, by Application
        • 12.3.3.2.4.1 China: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
        • 12.3.3.2.5 China: Rapid Test Kits Market Breakdown, by End User
      • 12.3.3.3 Japan: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.3.3.3.1 Overview
      • 12.3.3.4 Japan: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.3.3.4.1 Japan: Rapid Test Kits Market Breakdown, by Type
        • 12.3.3.4.2 Japan: Rapid Test Kits Market Breakdown, by Product
        • 12.3.3.4.3 Japan: Rapid Test Kits Market Breakdown, by Technology
        • 12.3.3.4.4 Japan: Rapid Test Kits Market Breakdown, by Application
        • 12.3.3.4.4.1 Japan: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
        • 12.3.3.4.5 Japan: Rapid Test Kits Market Breakdown, by End User
      • 12.3.3.5 India: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.3.3.5.1 Overview
      • 12.3.3.6 India: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.3.3.6.1 India: Rapid Test Kits Market Breakdown, by Type
        • 12.3.3.6.2 India: Rapid Test Kits Market Breakdown, by Product
        • 12.3.3.6.3 India: Rapid Test Kits Market Breakdown, by Technology
        • 12.3.3.6.4 India: Rapid Test Kits Market Breakdown, by Application
        • 12.3.3.6.4.1 India: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
        • 12.3.3.6.5 India: Rapid Test Kits Market Breakdown, by End User
      • 12.3.3.7 Australia: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.3.3.7.1 Overview
      • 12.3.3.8 Australia: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.3.3.8.1 Australia: Rapid Test Kits Market Breakdown, by Type
        • 12.3.3.8.2 Australia: Rapid Test Kits Market Breakdown, by Product
        • 12.3.3.8.3 Australia: Rapid Test Kits Market Breakdown, by Technology
        • 12.3.3.8.4 Australia: Rapid Test Kits Market Breakdown, by Application
        • 12.3.3.8.4.1 Australia: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
        • 12.3.3.8.5 Australia: Rapid Test Kits Market Breakdown, by End User
      • 12.3.3.9 South Korea: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.3.3.9.1 Overview
      • 12.3.3.10 South Korea: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.3.3.10.1 South Korea: Rapid Test Kits Market Breakdown, by Type
        • 12.3.3.10.2 South Korea: Rapid Test Kits Market Breakdown, by Product
        • 12.3.3.10.3 South Korea: Rapid Test Kits Market Breakdown, by Technology
        • 12.3.3.10.4 South Korea: Rapid Test Kits Market Breakdown, by Application
        • 12.3.3.10.4.1 South Korea: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
        • 12.3.3.10.5 South Korea: Rapid Test Kits Market Breakdown, by End User
      • 12.3.3.11 Rest of APAC: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.3.3.11.1 Overview
      • 12.3.3.12 Rest of APAC: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.3.3.12.1 Rest of APAC: Rapid Test Kits Market Breakdown, by Type
        • 12.3.3.12.2 Rest of APAC: Rapid Test Kits Market Breakdown, by Product
        • 12.3.3.12.3 Rest of APAC: Rapid Test Kits Market Breakdown, by Technology
        • 12.3.3.12.4 Rest of APAC: Rapid Test Kits Market Breakdown, by Application
        • 12.3.3.12.4.1 Rest of APAC: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
        • 12.3.3.12.5 Rest of APAC: Rapid Test Kits Market Breakdown, by End User
  • 12.4 Middle East and Africa
    • 12.4.1 Overview
    • 12.4.2 Middle East and Africa: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
      • 12.4.2.1 Middle East and Africa: Rapid Test Kits Market - Revenue and Forecast Analysis - by Type
      • 12.4.2.2 Middle East and Africa: Rapid Test Kits Market - Revenue and Forecast Analysis - by Product
      • 12.4.2.3 Middle East and Africa: Rapid Test Kits Market - Revenue and Forecast Analysis - by Technology
      • 12.4.2.4 Middle East and Africa: Rapid Test Kits Market - Revenue and Forecast Analysis - by Application
        • 12.4.2.4.1 Middle East and Africa: Rapid Test Kits Market - Revenue and Forecast Analysis - by Infectious Disease Testing
      • 12.4.2.5 Middle East and Africa: Rapid Test Kits Market - Revenue and Forecast Analysis - by End User
    • 12.4.3 Middle East and Africa: Rapid Test Kits Market - Revenue and Forecast Analysis - by Country
      • 12.4.3.1 Saudi Arabia: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.4.3.1.1 Overview
      • 12.4.3.2 Saudi Arabia: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.4.3.2.1 Saudi Arabia: Rapid Test Kits Market Breakdown, by Type
        • 12.4.3.2.2 Saudi Arabia: Rapid Test Kits Market Breakdown, by Product
        • 12.4.3.2.3 Saudi Arabia: Rapid Test Kits Market Breakdown, by Technology
        • 12.4.3.2.4 Saudi Arabia: Rapid Test Kits Market Breakdown, by Application
        • 12.4.3.2.4.1 Saudi Arabia: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
        • 12.4.3.2.5 Saudi Arabia: Rapid Test Kits Market Breakdown, by End User
      • 12.4.3.3 South Africa: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.4.3.3.1 Overview
      • 12.4.3.4 South Africa: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.4.3.4.1 South Africa: Rapid Test Kits Market Breakdown, by Type
        • 12.4.3.4.2 South Africa: Rapid Test Kits Market Breakdown, by Product
        • 12.4.3.4.3 South Africa: Rapid Test Kits Market Breakdown, by Technology
        • 12.4.3.4.4 South Africa: Rapid Test Kits Market Breakdown, by Application
        • 12.4.3.4.4.1 South Africa: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
        • 12.4.3.4.5 South Africa: Rapid Test Kits Market Breakdown, by End User
      • 12.4.3.5 United Arab Emirates: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.4.3.5.1 Overview
      • 12.4.3.6 United Arab Emirates: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.4.3.6.1 United Arab Emirates: Rapid Test Kits Market Breakdown, by Type
        • 12.4.3.6.2 United Arab Emirates: Rapid Test Kits Market Breakdown, by Product
        • 12.4.3.6.3 United Arab Emirates: Rapid Test Kits Market Breakdown, by Technology
        • 12.4.3.6.4 United Arab Emirates: Rapid Test Kits Market Breakdown, by Application
        • 12.4.3.6.4.1 United Arab Emirates: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
        • 12.4.3.6.5 United Arab Emirates: Rapid Test Kits Market Breakdown, by End User
      • 12.4.3.7 Rest of Middle East and Africa: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.4.3.7.1 Overview
      • 12.4.3.8 Rest of Middle East and Africa: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.4.3.8.1 Rest of Middle East and Africa: Rapid Test Kits Market Breakdown, by Type
        • 12.4.3.8.2 Rest of Middle East and Africa: Rapid Test Kits Market Breakdown, by Product
        • 12.4.3.8.3 Rest of Middle East and Africa: Rapid Test Kits Market Breakdown, by Technology
        • 12.4.3.8.4 Rest of Middle East and Africa: Rapid Test Kits Market Breakdown, by Application
        • 12.4.3.8.4.1 Rest of Middle East and Africa: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
        • 12.4.3.8.5 Rest of Middle East and Africa: Rapid Test Kits Market Breakdown, by End User
  • 12.5 South and Central America
    • 12.5.1 Overview
    • 12.5.2 South and Central America: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
      • 12.5.2.1 South and Central America: Rapid Test Kits Market - Revenue and Forecast Analysis - by Type
      • 12.5.2.2 South and Central America: Rapid Test Kits Market - Revenue and Forecast Analysis - by Product
      • 12.5.2.3 South and Central America: Rapid Test Kits Market - Revenue and Forecast Analysis - by Technology
      • 12.5.2.4 South and Central America: Rapid Test Kits Market - Revenue and Forecast Analysis - by Application
      • 12.5.2.5 South and Central America: Rapid Test Kits Market - Revenue and Forecast Analysis - by Infectious Disease Testing
      • 12.5.2.6 South and Central America: Rapid Test Kits Market - Revenue and Forecast Analysis - by End User
    • 12.5.3 South and Central America: Rapid Test Kits Market - Revenue and Forecast Analysis - by Country
      • 12.5.3.1 Brazil: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.5.3.1.1 Overview
      • 12.5.3.2 Brazil: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.5.3.2.1 Brazil: Rapid Test Kits Market Breakdown, by Type
        • 12.5.3.2.2 Brazil: Rapid Test Kits Market Breakdown, by Product
        • 12.5.3.2.3 Brazil: Rapid Test Kits Market Breakdown, by Technology
        • 12.5.3.2.4 Brazil: Rapid Test Kits Market Breakdown, by Application
        • 12.5.3.2.4.1 Brazil: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
        • 12.5.3.2.5 Brazil: Rapid Test Kits Market Breakdown, by End User
      • 12.5.3.3 Argentina: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.5.3.3.1 Overview
      • 12.5.3.4 Argentina: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.5.3.4.1 Argentina: Rapid Test Kits Market Breakdown, by Type
        • 12.5.3.4.2 Argentina: Rapid Test Kits Market Breakdown, by Product
        • 12.5.3.4.3 Argentina: Rapid Test Kits Market Breakdown, by Technology
        • 12.5.3.4.4 Argentina: Rapid Test Kits Market Breakdown, by Application
        • 12.5.3.4.4.1 Argentina: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
        • 12.5.3.4.5 Argentina: Rapid Test Kits Market Breakdown, by End User
      • 12.5.3.5 Rest of South and Central America: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.5.3.5.1 Overview
      • 12.5.3.6 Rest of South and Central America: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.5.3.6.1 Rest of South and Central America: Rapid Test Kits Market Breakdown, by Type
        • 12.5.3.6.2 Rest of South and Central America: Rapid Test Kits Market Breakdown, by Product
        • 12.5.3.6.3 Rest of South and Central America: Rapid Test Kits Market Breakdown, by Technology
        • 12.5.3.6.4 Rest of South and Central America: Rapid Test Kits Market Breakdown, by Application
        • 12.5.3.6.4.1 Rest of South and Central America: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
        • 12.5.3.6.5 Rest of South and Central America: Rapid Test Kits Market Breakdown, by End User

13. Industry Landscape

  • 13.1 Overview
  • 13.2 Growth Strategies in the Rapid Test Kit Market
  • 13.3 Inorganic Growth Strategies
    • 13.3.1 Overview
  • 13.4 Organic Growth Strategies
    • 13.4.1 Overview

14. Company Profiles

  • 14.1 F. Hoffmann-La Roche Ltd
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 Becton Dickinson and Co
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Products and Services
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 ARKRAY Inc
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Products and Services
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 Sysmex Partec GmbH
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Products and Services
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 Fujirebio Europe NV
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Products and Services
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments
  • 14.6 bioMerieux SA
    • 14.6.1 Key Facts
    • 14.6.2 Business Description
    • 14.6.3 Products and Services
    • 14.6.4 Financial Overview
    • 14.6.5 SWOT Analysis
    • 14.6.6 Key Developments
  • 14.7 Cepheid
    • 14.7.1 Key Facts
    • 14.7.2 Business Description
    • 14.7.3 Products and Services
    • 14.7.4 Financial Overview
    • 14.7.5 SWOT Analysis
    • 14.7.6 Key Developments
  • 14.8 Meril Life Sciences Pvt Ltd
    • 14.8.1 Key Facts
    • 14.8.2 Business Description
    • 14.8.3 Products and Services
    • 14.8.4 Financial Overview
    • 14.8.5 SWOT Analysis
    • 14.8.6 Key Developments
  • 14.9 QIAGEN NV
    • 14.9.1 Key Facts
    • 14.9.2 Business Description
    • 14.9.3 Products and Services
    • 14.9.4 Financial Overview
    • 14.9.5 SWOT Analysis
    • 14.9.6 Key Developments
  • 14.10 OraSure Technologies Inc
    • 14.10.1 Key Facts
    • 14.10.2 Business Description
    • 14.10.3 Products and Services
    • 14.10.4 Financial Overview
    • 14.10.5 SWOT Analysis
    • 14.10.6 Key Developments
  • 14.11 Guangzhou Wondfo Biotech Co Ltd
    • 14.11.1 Key Facts
    • 14.11.2 Business Description
    • 14.11.3 Products and Services
    • 14.11.4 Financial Overview
    • 14.11.5 SWOT Analysis
    • 14.11.6 Key Developments
  • 14.12 Denka Co Ltd
    • 14.12.1 Key Facts
    • 14.12.2 Business Description
    • 14.12.3 Products and Services
    • 14.12.4 Financial Overview
    • 14.12.5 SWOT Analysis
    • 14.12.6 Key Developments
  • 14.13 Abbott Laboratories
    • 14.13.1 Key Facts
    • 14.13.2 Business Description
    • 14.13.3 Products and Services
    • 14.13.4 Financial Overview
    • 14.13.5 SWOT Analysis
    • 14.13.6 Key Developments
  • 14.14 Trinity Biotech Plc
    • 14.14.1 Key Facts
    • 14.14.2 Business Description
    • 14.14.3 Products and Services
    • 14.14.4 Financial Overview
    • 14.14.5 SWOT Analysis
    • 14.14.6 Key Developments
  • 14.15 SD Biosensor Inc
    • 14.15.1 Key Facts
    • 14.15.2 Business Description
    • 14.15.3 Products and Services
    • 14.15.4 Financial Overview
    • 14.15.5 SWOT Analysis
    • 14.15.6 Key Developments
  • 14.16 Bio-Rad Laboratories Inc
    • 14.16.1 Key Facts
    • 14.16.2 Business Description
    • 14.16.3 Products and Services
    • 14.16.4 Financial Overview
    • 14.16.5 SWOT Analysis
    • 14.16.6 Key Developments
  • 14.17 Hologic Inc
    • 14.17.1 Key Facts
    • 14.17.2 Business Description
    • 14.17.3 Products and Services
    • 14.17.4 Financial Overview
    • 14.17.5 SWOT Analysis
    • 14.17.6 Key Developments
  • 14.18 DiaSorin SpA
    • 14.18.1 Key Facts
    • 14.18.2 Business Description
    • 14.18.3 Products and Services
    • 14.18.4 Financial Overview
    • 14.18.5 SWOT Analysis
    • 14.18.6 Key Developments
  • 14.19 Premier Medical Corp Pvt Ltd
    • 14.19.1 Key Facts
    • 14.19.2 Business Description
    • 14.19.3 Products and Services
    • 14.19.4 Financial Overview
    • 14.19.5 SWOT Analysis
    • 14.19.6 Key Developments
  • 14.20 Beckman Coulter Inc
    • 14.20.1 Key Facts
    • 14.20.2 Business Description
    • 14.20.3 Products and Services
    • 14.20.4 Financial Overview
    • 14.20.5 SWOT Analysis
    • 14.20.6 Key Developments

15. Appendix

  • 15.1 About The Insight Partners
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦